A New Perspective of COVID-19 Infection: An Epigenetics Point of View

Overview

Journal Glob Med Genet

Publisher Thieme

Date 2022 Feb 16

PMID 35169776

Authors

Ziya Ozturkler

Rasime Kalkan

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-2019) started in Wuhan, China, in December 2019. Angiotensin-converting enzyme 2 (ACE2) receptor was one of the most important genes related to the entrance of the virus to the host. Until now, several variations have been identified in ACE2 and related transmembrane protease serine 2. Epigenetic modifications not only play an important role during the maintenance of genome and cellular homoeostasis but also for the etiopathophysiology of the virus infection. Studies showed methylation of ACE2 was changed to depend on host and age of the host during the viral infection. In this study, we provided an epigenetics point of view to the coronavirus infection. We highlight the importance of epigenetic modifications during viral replication and infection and their interaction with COVID-19 susceptibility and host viral response.

Citing Articles

Improving the odds of survival: transgenerational effects of infections.

Spanou V, Andriopoulou T, Giamarellos-Bourboulis E, Netea M EMBO Mol Med. 2025; .

PMID: 39843630 DOI: 10.1038/s44321-025-00192-9.

An Epigenetic Locus Associated with Loss of Smell in COVID-19.

Aslan E, White K, Meral G, Akcay Z, Altundag A, Gur S Diagnostics (Basel). 2025; 14(24.

PMID: 39767184 PMC: 11675069. DOI: 10.3390/diagnostics14242823.

Long COVID science, research and policy.

Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A Nat Med. 2024; 30(8):2148-2164.

PMID: 39122965 DOI: 10.1038/s41591-024-03173-6.

Pulmonary Pathogen-Induced Epigenetic Modifications.

Wrede D, Bordak M, Abraham Y, Mehedi M Epigenomes. 2023; 7(3).

PMID: 37489401 PMC: 10366755. DOI: 10.3390/epigenomes7030013.

Unspoken Consequences of Structural Racism in the USA: Diabetes and COVID-19.

Taikeff N, Achkar A, Naous E, Mitri J J Racial Ethn Health Disparities. 2023; 11(5):2575-2582.

PMID: 37460920 DOI: 10.1007/s40615-023-01722-2.

References

Tukiainen T, Villani A, Yen A, Rivas M, Marshall J, Satija R . Landscape of X chromosome inactivation across human tissues. Nature. 2017; 550(7675):244-248. PMC: 5685192. DOI: 10.1038/nature24265. View

Papa G, Mallery D, Albecka A, Welch L, Cattin-Ortola J, Luptak J . Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion. PLoS Pathog. 2021; 17(1):e1009246. PMC: 7861537. DOI: 10.1371/journal.ppat.1009246. View

Lee J, Park S, Jeong H, Ahn J, Choi S, Lee H . Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci Immunol. 2020; 5(49). PMC: 7402635. DOI: 10.1126/sciimmunol.abd1554. View

Pinto B, Oliveira A, Singh Y, Jimenez L, Goncalves A, Ogava R . ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19. J Infect Dis. 2020; 222(4):556-563. PMC: 7377288. DOI: 10.1093/infdis/jiaa332. View

Wan Y, Shang J, Graham R, Baric R, Li F . Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020; 94(7). PMC: 7081895. DOI: 10.1128/JVI.00127-20. View

Wilk A, Rustagi A, Zhao N, Roque J, Martinez-Colon G, McKechnie J . A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. 2020; 26(7):1070-1076. PMC: 7382903. DOI: 10.1038/s41591-020-0944-y. View

Sawalha A, Zhao M, Coit P, Lu Q . Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol. 2020; 215:108410. PMC: 7139239. DOI: 10.1016/j.clim.2020.108410. View

Blanco-Melo D, Nilsson-Payant B, Liu W, Uhl S, Hoagland D, Moller R . Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19. Cell. 2020; 181(5):1036-1045.e9. PMC: 7227586. DOI: 10.1016/j.cell.2020.04.026. View

Ragia G, Manolopoulos V . Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry. Pharmacogenomics. 2020; 21(18):1311-1329. PMC: 7694444. DOI: 10.2217/pgs-2020-0092. View

10.

Galupa R, Heard E . X-Chromosome Inactivation: A Crossroads Between Chromosome Architecture and Gene Regulation. Annu Rev Genet. 2018; 52:535-566. DOI: 10.1146/annurev-genet-120116-024611. View

11.

Chlamydas S, Papavassiliou A, Piperi C . Epigenetic mechanisms regulating COVID-19 infection. Epigenetics. 2020; 16(3):263-270. PMC: 7901548. DOI: 10.1080/15592294.2020.1796896. View

12.

Corley M, Pang A, Dody K, Mudd P, Patterson B, Seethamraju H . Genome-wide DNA methylation profiling of peripheral blood reveals an epigenetic signature associated with severe COVID-19. J Leukoc Biol. 2021; 110(1):21-26. PMC: 8013321. DOI: 10.1002/JLB.5HI0720-466R. View